Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 4 , Pages 297-305 , December 2007

Tumor imaging using technetium-99m bound to pH-sensitive peptides

  • John E. Mata, PhD

      Affiliations

    • Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA
    • Corresponding Author InformationCorresponding author. Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.
    • ,
  • Leslie A. Dyal, PhD

      Affiliations

    • Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA
    • ,
  • Margorie E. Slauson, MS

      Affiliations

    • Department of Nuclear Engineering and Radiation Health Physics, Oregon State University, Corvallis, Oregon, USA
    • ,
  • James E. Summerton, PhD

      Affiliations

    • Gene Tools, LLC, Philomath, Oregon, USA
    • ,
  • Christiane Loehr, DVM, PhD

      Affiliations

    • Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA
    • ,
  • Arhie Reid Tyson, DVM

      Affiliations

    • Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA
    • ,
  • Rosita Rodriguez-Proteau, PhD

      Affiliations

    • Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA
    • ,
  • Scott B. Gustafson, DVM

      Affiliations

    • Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA

Received 4 May 2007 ,Accepted 15 August 2007.

References 

  1. Mordon S, Devoisselle JM, Maunoury V. In vivo pH measurement and imaging of tumor tissue using a pH-sensitive fluorescent probe (5,6-carboxyfluorescein): instrumental and experimental studies. Photochem Photobiol. 1994;60:274–279
  2. Tagashira Y, Takeda S, Kawano K, Amano S. Continuous pH measuring by means of microglass electrode inserted in living normal and tumor tissues (2nd report), with an additional report on interaction of SH-group of animal protein with carcinogenic agent in the carcinogenetic mechanism. Gan. 1954;45:99–101
  3. Thistlethwaite AJ, Alexander GA, Moylan DJ, Leeper DB. Modification of human tumor pH by elevation of blood glucose. Int J Radiat Oncol Biol Phys. 1987;13:603–610
  4. Drexler KE. Molecular engineering: an approach to the development of general capabilities for molecular manipulation. Proc Natl Acad Sci U S A. 1981;78:5275–5278
  5. Mata JE, Dyal LA, Rossi VM, Gustafson SB. Solid tumor physiology as a target for nanomedicines. In:  Nalwa HS,  Webster T editor. Cancer Nanomedicine Cancer Nanotechnology—Nanomaterials for cancer diagnosis and therapy. Valencia (Calif): American Scientific Publishers; 2006;p. 215–233
  6. Reshetnyak YK, Andreev OA, Lehnert U, Engelman DM. Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix. Proc Natl Acad Sci U S A. 2006;103:6460–6465
  7. Summerton J.E. Transporter compositions and methods for detecting and killing cells in acidic areas of tumors. Published United States patent application 7,132,393.
  8. Summerton J, Weller D. Molecular engine for transporting drugs across cell membranes. Nucleosides Nucleotides. 1997;16:1785–1788
  9. Summerton J, Weller D. Polypeptide composition able to reversibly transmit between lipophilic and hydrophilic forms—useful for transporting compounds across lipid layers. Published international patent application 97-549493/50 (1997).
  10. Rusckowski M, Qu T, Gupta S, Ley A, Hnatowich DJ. A comparison in monkeys of (99m)Tc labeled to a peptide by 4 methods. J Nucl Med. 2001;42:1870–1877
  11. Gerweck LE, Vijayappa S, Kozin S. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther. 2006;5:1275–1279
  12. McSheehy PM, Stubbs M, Griffiths JR. Role of pH in tumor-trapping of the anticancer drug 5-fluorouracil. Adv Enzyme Regul. 2000;40:63–80
  13. Laurencot CM, Kennedy KA. Influence of pH on the cytotoxicity of cisplatin in EMT6 mouse mammary tumor cells. Oncol Res. 1995;7:371–379
  14. Raghunand N, Mahoney BP, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol. 2003;66:1219–1229
  15. Mahoney BP, Raghunand N, Baggett B, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol. 2003;66:1207–1218
  16. Junior AD, Mota LG, Nunan EA, Wainstein AJ, Wainstein AP, Leal AS. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice. Life Sci. 2007;80:659–664
  17. Sethuraman VA, Na K, Bae YH. pH-responsive sulfonamide/PEI system for tumor specific gene delivery: an in vitro study. Biomacromolecules. 2006;7:64–70
  18. Shenoy D, Little S, Langer R, Amiji M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies. Pharm Res. 2005;22:2107–2114
  19. Mrkvan T, Sirova M, Etrych T, Chytil P, Strohalm J, Plocova D. Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity. J Control Release. 2005;110:119–129
  20. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56:1649–1659
  21. Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer. 2004;109:759–767
  22. Oyewumi MO, Yokel RA, Jay M, Coakley T, Mumper RJ. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control Release. 2004;95:613–626
  23. Lu Z, Yeh TK, Tsai M, Au JL, Wientjes MG. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res. 2004;10:7677–7684
  24. Guccione S, Li KC, Bednarski MD. Vascular-targeted nanoparticles for molecular imaging and therapy. Methods Enzymol. 2004;386:219–236

 Dr. Summerton is owner and manager of Gene Tools, LLC, which is developing the peptides used in this studies for medical use. Other authors listed have no conflict of interest.

PII: S1549-9634(07)00117-7

doi: 10.1016/j.nano.2007.08.001

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 4 , Pages 297-305 , December 2007

Article Tools

* Image Usage & Resolution